These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27537739)

  • 1. Late neoatherosclerotic scaffold failure: An unexpected achilles heel for current bioresorbable scaffold technology?
    Hiltrop N; Jorge C; Bennett J; Adriaenssens T
    Int J Cardiol; 2016 Nov; 223():133-135. PubMed ID: 27537739
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioresorbable vascular scaffolds: implication of very late scaffold thrombosis.
    Mori H; Virmani R; Finn AV
    Coron Artery Dis; 2017 Nov; 28(7):533-538. PubMed ID: 28692483
    [No Abstract]   [Full Text] [Related]  

  • 3. Optical Coherence Tomography of Magnesium Bioresorbable Scaffold Restenosis.
    García-Blas S; Miñana G; Sanchis J
    Rev Esp Cardiol (Engl Ed); 2018 Dec; 71(12):1069. PubMed ID: 29223376
    [No Abstract]   [Full Text] [Related]  

  • 4. Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold at 8 Months.
    Kang SH; Kang SJ; Kim WJ
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1896-1898. PubMed ID: 28866035
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioresorbable Vascular Scaffold Thrombosis: Clinical and Optical Coherence Tomography Findings.
    Cuesta J; García-Guimaraes M; Basante T; Rivero F; Antuña P; Alfonso F
    Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):90-91. PubMed ID: 29223378
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
    Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
    Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac allograft vasculopathy: optical coherence guided innovative treatment options with the bioresorbable vascular scaffold: proof of concept.
    Édes IF; Hajas Á; Sax B; Bartykowszki A; Becker D; Merkely B
    Minerva Cardioangiol; 2016 Aug; 64(4):487-93. PubMed ID: 27152623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid- to long-term outcome of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Data of the BVS registry Göttingen predominantly from ACS patients.
    Hellenkamp K; Becker A; Gabriel YD; Hasenfuß G; Hünlich M; Jacobshagen C; Schillinger W; Schroeter MR
    Int J Cardiol; 2017 May; 234():58-63. PubMed ID: 28258843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoatherosclerosis in a Bare Metal Stent: A New Problem of Atherosclerosis.
    Asher E; Guetta V; Segev A
    Isr Med Assoc J; 2016 May; 18(5):306. PubMed ID: 27430092
    [No Abstract]   [Full Text] [Related]  

  • 11. Restored Physiological Vasomotion Imitating Intrascaffold Restenosis 3 Years After Bioresorbable Scaffold Implantation.
    Ancona MB; Tanaka A; Latib A; Jabbour RJ; Kawamoto H; Regazzoli D; Mangieri A; Colombo A
    Can J Cardiol; 2016 Dec; 32(12):1574.e9-1574.e10. PubMed ID: 27211844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of post-dilatation on strut apposition of second-generation bioresorbable vascular scaffolds: Key role for scaffold thrombosis and prognosis?
    Frangieh AH; Jaguszewski M; Imori Y; Obeid S; Templin C
    Cardiol J; 2018; 25(1):148-150. PubMed ID: 29512102
    [No Abstract]   [Full Text] [Related]  

  • 13. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
    Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
    [No Abstract]   [Full Text] [Related]  

  • 14. Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions.
    Abizaid A; Costa RA; Schofer J; Ormiston J; Maeng M; Witzenbichler B; Botelho RV; Costa JR; Chamié D; Abizaid AS; Castro JP; Morrison L; Toyloy S; Bhat V; Yan J; Verheye S
    JACC Cardiovasc Interv; 2016 Mar; 9(6):565-74. PubMed ID: 27013155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.
    Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of BVS implantation: a focus on safety and efficacy of the bioresorbable technology.
    DEN Dekker WK; VAN Geuns RJ; Diletti R
    Minerva Cardioangiol; 2016 Aug; 64(4):462-72. PubMed ID: 27175976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful use of bioresorbable vascular scaffold in in-stent restenosis previously exposed to vascular brachytherapy.
    Wong KL; Fan KY; Jim MH
    Int J Cardiol; 2015 Feb; 181():1-2. PubMed ID: 25473779
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold.
    Vanhaverbeke M; McCutcheon K; Dubois C; Bennett J
    Acta Cardiol; 2018 Aug; 73(4):413-414. PubMed ID: 29277145
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1-year follow-up: A systematic review and meta-analysis of studies.
    Mukete BN; van der Heijden LC; Tandjung K; Baydoun H; Yadav K; Saleh QA; Doggen CJ; Abi Rafeh N; Le Jemtel TH; von Birgelen C
    Int J Cardiol; 2016 Oct; 221():1087-94. PubMed ID: 27448538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and receding of a coronary artery aneurysm after implantation of a fully bioresorbable scaffold.
    Nakatani S; Ishibashi Y; Suwannasom P; Grundeken MJ; Høj Christiansen E; Onuma Y; Serruys PW;
    Circulation; 2015 Feb; 131(8):764-7. PubMed ID: 25712060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.